Treatment with liraglutide (3.0 mg once daily for 3 years), a glucagon-like peptide 1 receptor agonist that lowers levels of glucose and reduces body weight, reduced the risk of 'on treatment' type 2 ...
Polyneuropathy occurs when multiple peripheral nerves malfunction throughout the body. Neuropathy is a common complication of type 2 diabetes mellitus (T2DM). Polyneuropathy occurs when there is ...
Targeting glucose control and managing cardiovascular (CV) risk factors may prevent future CV events, and have positive downstream impact by reducing costs to healthcare stakeholders.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results